We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$115B
AUM Growth
+$6.24B
Cap. Flow
+$1B
Cap. Flow %
0.87%
Top 10 Hldgs %
23.71%
Holding
4,165
New
247
Increased
1,898
Reduced
1,581
Closed
296

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$413M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$248M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$109M
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$76.1M
5
MBB icon
iShares MBS ETF
MBB
+$75.1M

Top Sells

Rank Stock Value
1
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$551M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$184M
3
AOR icon
iShares Core 60/40 Balanced Allocation ETF
AOR
+$97.8M
4
VT icon
Vanguard Total World Stock ETF
VT
+$83M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$67.3M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Healthcare 8.69%
3 Financials 8.53%
4 Industrials 6.69%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPBT
3776
Purple Biotech
PPBT
$2.52M
$19.7K ﹤0.01%
+55
New +$20.6K
HYFM icon
3777
Hydrofarm Holdings
HYFM
$7.96M
$19.7K ﹤0.01%
1,138
-7,118
-86% -$126K
SNCR
3778
DELISTED
Synchronoss Technologies
SNCR
$19.3K ﹤0.01%
2,282
-5
-0.2% -$40
VSTM icon
3779
Verastem
VSTM
$638M
$18.6K ﹤0.01%
3,725
-104
-3% -$658
MLSS icon
3780
Milestone Scientific
MLSS
$43M
$18K ﹤0.01%
20,000
– –
PDYN icon
3781
Palladyne AI
PDYN
$312M
$16.6K ﹤0.01%
5,833
– –
QTTB icon
3782
Q32 Bio
QTTB
$459M
$16.4K ﹤0.01%
884
– –
FUBO icon
3783
FuboTV Inc
FUBO
$293M
$16.2K ﹤0.01%
1,119
-20
-2% -$457
PFE icon
3784
CALL
Pfizer
PFE
$152B
$16K ﹤0.01%
400
-29,400
-99% -$1.27M
SFT
3785
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$15.9K ﹤0.01%
14,203
-218
-2% -$443
LMDX
3786
DELISTED
LumiraDx Limited Common Shares
LMDX
$15.3K ﹤0.01%
32,841
+2,086
+7% +$2K
EGIO
3787
DELISTED
Edgio, Inc. Common Stock
EGIO
$14.9K ﹤0.01%
470
-17
-3% -$838
FIRY
3788
Firy Inc
FIRY
$160M
$13.4K ﹤0.01%
1,133
-631
-36% -$8.37K
INO icon
3789
Inovio Pharmaceuticals
INO
$79.1M
$13.2K ﹤0.01%
1,339
+64
+5% +$1.09K
GYRE icon
3790
Gyre Therapeutics
GYRE
$704M
$13K ﹤0.01%
4,193
-143
-3% -$543
ACB
3791
Aurora Cannabis
ACB
$216M
$13K ﹤0.01%
1,866
-165
-8% -$1.44K
AZ icon
3792
A2Z Smart Technologies
AZ
$298M
$12.9K ﹤0.01%
+4,000
New +$15.8K
PAVM icon
3793
PAVmed
PAVM
$33.7M
$12.3K ﹤0.01%
73
– –
ADAP
3794
DELISTED
Adaptimmune Therapeutics
ADAP
$12.3K ﹤0.01%
11,298
+1,250
+12% +$1.94K
AXDX
3795
DELISTED
Accelerate Diagnostics
AXDX
$12.2K ﹤0.01%
1,750
– –
WE
3796
DELISTED
WeWork Inc.
WE
$11.8K ﹤0.01%
380
-250
-40% -$13.7K
DWTX
3797
Dogwood Therapeutics
DWTX
$61.9M
$11K ﹤0.01%
1,200
– –
GOEV
3798
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$10.7K ﹤0.01%
36
+1
+3% +$424
KRRO icon
3799
Korro Bio
KRRO
$196M
$10.6K ﹤0.01%
+420
New +$47.9K
SENS icon
3800
Senseonics Holdings Inc
SENS
$416M
$10.2K ﹤0.01%
722
– –
150 151
152
153 154

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Raymond James & Associates held 4,165 positions worth $115B, up 5.7% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q1 2023 filing shows 247 new, 1,898 increased, 1,581 reduced and 296 closed positions. Its largest new stake was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2023 buy was VanEck Morningstar International Moat ETF: 787,215 shares worth $25.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2023, an estimated $413M increase.
  • Raymond James & Associates's biggest Q1 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $18.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $115B portfolio in Q1 2023.
  • Raymond James & Associates opened 247 new positions and closed 296 in Q1 2023.
  • Raymond James & Associates's portfolio value rose 5.7% quarter-over-quarter to $115B.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.